Semaglutide 3-month plans
A 3-month rate is a commitment rate. The plan column shows how it bills; 12-month totals that assume renewal at the same rate say so in the row.
As of August 31, 2026:
The lowest 3-month compounded semaglutide rate in the database is NexLife at $132 per month on a 3-month plan, billing frequency not stated (grade A). 3 providers publish a verified 3-month rate. Where the 12-month column assumes renewal at the same 3-month rate, the assumption is printed on the row rather than hidden in a footnote.
| # | Provider | Plan | Advertised /mo | All-in /mo, maintenance dose | 12-month all-in | Dose pricing | Membership | Included | Grade | Verified | Change | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NexLifecompounded injectable | 3-month plan, billing not stated | $132 | $132 | $1,584 | same at every dose | none | care and shipping | A | — | nexlife.us | |
| 2 | Ozari Healthcompounded injectable | 3-month plan, billing not stated | $145 | $145 | $1,563 | not stated | none | care: not published; shipping included | B | — | ozarihealth.com | |
| 3 | Noom Medcompounded injectable | 3-month plan, billing not stated | $249 | $249 | $2,868 | same at every dose | none | care and shipping | A | — | noom.com |
Grades: A = price and terms verified on the provider’s page; B = price verified, some terms unpublished; C = introductory price only; D = third-party report, not verified by us; U = no public price. Grade D rows are shown for completeness and are never counted in verified statistics. Full definitions.